Medical Patent Business Week
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Medical Patent Business Week
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Nanophases
Nanophase Announces New Patent
January 25th, 2008
Nanophase Technologies (NASDAQ:NANX), a technology leader in nanomaterials and advanced nanoengineered products, announces that the Company has been issued U.S. Patent No. 7,303,891 -- entitled "Surface Treatment of Nanoparticles to Control Interfacial Properties and Method of Manufacture". The patent discloses the formation of surface treated nanoparticles with looped and/or linear polymeric structure on a star-graft polymer coating. Nanophase's novel surface treatment controls the interfacial properties of the nanoparticle with controlled polymer physical properties and controlled polymeric chemical properties. Nanophase now owns or licenses 18 United States and 49 foreign patents and...
Source: Medical Patent Business Week (2008-01-25)
|